Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 30 04 2022
accepted: 29 06 2022
pubmed: 22 7 2022
medline: 27 8 2022
entrez: 21 7 2022
Statut: ppublish

Résumé

The aim of the current study is to evaluate the association between below-the-ankle (BTA) arterial disease and coronary artery disease (CAD) in patients with diabetic foot ulcers (DFUs). The study group was composed of patients with an active neuro-ischaemic DFUs managed in a tertiary care diabetic foot clinic. All patients received a pre-set limb salvage protocol including lower limb revascularization. By a retrospective analysis of individual angiograms, patients were divided in two groups: below-the-ankle (BTA) and above-the-ankle (ATA) arterial disease groups. The rate of CAD at baseline assessment and the new events of acute myocardial ischaemia (AMI) during 1-year of follow-up were evaluated and compared between the two groups. Two hundreds seventy-two (272) patients were included, 120 (44.1%) showed BTA arterial disease while 152 (55.9%) ATA arterial disease. The mean age was 68.9 ± 9.6 years, 198 (72.8%) were male, 246 (90.4%) had type 2 diabetes, the mean diabetes duration was 20.7 ± 11.6 years, the mean HbA1c was 7.8 ± 4.2% (62 ± 22 mmmol/mol). The whole population reported CAD in 172 cases (63.4%), and the rate in the BTA group was significantly higher than in ATA group, respectively, 90 (75.4%) vs 82 (54.1%), p < 0.0001. During the follow-up, BTA group had 5% of new cases of AMI in comparison to 1.3% in ATA group (p < 0.001). At the multivariate analysis BTA resulted an independent marker of CAD [OR 1.9 CI 9 5% (1.3-4.5) p = 0.0001]. The current study shows a significant association between BTA arterial disease and CAD. A close cardiovascular screen should be required in patients with DFUs.

Identifiants

pubmed: 35864261
doi: 10.1007/s00592-022-01932-w
pii: 10.1007/s00592-022-01932-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1331-1338

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. Springer-Verlag Italia S.r.l., part of Springer Nature.

Références

American Diabetes Association (2020) 11 Microvascular Complications and Foot Care: Standards of medical care in Diabetes-2020. Diabetes Care. 2020 Jan; 43(Suppl 1):S135-S151. doi: https://doi.org/10.2337/dc20-S011 ( PMID: 31862754).
American Diabetes Association (2020) Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43(Suppl. 1):S111-S134. Diabetes Care. 2020 Aug; 43(8):1977–1978. doi: https://doi.org/10.2337/dc20-ad08 . Epub 2020 Jun 5. Erratum for: Diabetes Care. 2020 Jan; 43(Suppl 1):S111-S134. (PMID: 32503834)
Smolderen KG, Bell A, Lei Y et al. (2010) REACH registry investigators. One-year costs associated with cardiovascular disease in Canada: insights from the reduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. https://doi.org/10.1016/s0828-282x(10)70437-2
doi: 10.1016/s0828-282x(10)70437-2 pubmed: 20931098 pmcid: 2954538
Smolderen KG, Wang K, de Pouvourville G et al. (2012) Reach Registry Investigators. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg. https://doi.org/10.1016/j.ejvs.2011.09.016
doi: 10.1016/j.ejvs.2011.09.016 pubmed: 22001145
Sadrzadeh Rafie AH, Stefanick ML, Sims ST et al. (2010) Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization. Vasc Med 15(6):443–450. https://doi.org/10.1177/1358863X10388345
doi: 10.1177/1358863X10388345 pubmed: 21183651
Meloni M, Izzo V, Giurato L, Lázaro-Martínez JL, Uccioli L (2020) Prevalence, Clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: comparison between neuropathic and ischemic ulcers. J Clin Med 9(6):1780. https://doi.org/10.3390/jcm9061780 (PMID:32521700)
doi: 10.3390/jcm9061780.PMID:32521700 pubmed: 32521700 pmcid: 7356179
Spreen MI, Gremmels H, Teraa M et al. (2016) PADI and JUVENTAS Study groups. Diabetes is associated with decreased limb survival in patients with critical limb ischemia: pooled data from two randomized controlled trials. diabetes care, Nov; 39(11):2058–2064. doi: https://doi.org/10.2337/dc16-0850
Richter L, Freisinger E, Lüders F, Gebauer K, Meyborg M, Malyar NM (2018) Impact of diabetes type on treatment and outcome of patients with peripheral artery disease. Diab Vasc Dis Res 15(6):504–510. https://doi.org/10.1177/1479164118793986
doi: 10.1177/1479164118793986 pubmed: 30246546
Blinc A, Kozak M, Šabovič M et al. (2017) Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease. Int Angiol 36(3):216–227. https://doi.org/10.23736/S0392-9590.16.03731-7
doi: 10.23736/S0392-9590.16.03731-7 pubmed: 27332992
Prompers L, Schaper N, Apelqvist J et al. (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease The EURODIALE Study. Diabetologia. https://doi.org/10.1007/s00125-008-0940-0
doi: 10.1007/s00125-008-0940-0 pubmed: 18648766 pmcid: 2292424
Faglia E, Clerici G, Clerissi J et al. (2009) Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care. 2009 May;32(5):822–7. doi: https://doi.org/10.2337/dc08-1223 . Epub 2009 Feb 17. Erratum in: Diabetes Care. 2009 Jul;32(7):1355. Luppattelli, Tommaso [corrected to Lupattelli, Tommaso]. (PMID: 19223609);(PMCID: PMC2671089)
Uccioli L, Gandini R, Giurato L et al. (2010) Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic. Diabet Care. https://doi.org/10.2337/dc09-0831
doi: 10.2337/dc09-0831
Meloni M, Izzo V, Giurato L, Gandini R, Uccioli L (2019) Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers. Diabetes Res Clin Pract 152:9–15. https://doi.org/10.1016/j.diabres.2019.04.031
doi: 10.1016/j.diabres.2019.04.031 pubmed: 31078668
Ferraresi R, Mauri G, Losurdo F et al. (2018) BAD transmission and SAD distribution: a new scenario for critical limb ischemia. J Cardiovasc Surg (Torino) 59(5):655–664. https://doi.org/10.23736/S0021-9509.18.10572-6
doi: 10.23736/S0021-9509.18.10572-6 pubmed: 29786411
Meloni M, Morosetti D, Giurato L et al. (2021) Foot revascularization avoids major amputation in persons with diabetes and ischaemic foot ulcers. J Clin Med 10(17):3977. https://doi.org/10.3390/jcm10173977
doi: 10.3390/jcm10173977 pubmed: 34501432 pmcid: 8432560
Bus SA, Van Netten JJ, Hinchliffe RJ, Apelqvist J, Lipsky BA, Schaper NC; IWGDF Editorial Board (2020) Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines. Diabetes Metab Res Rev. Mar;36 Suppl 1:e3267. doi: https://doi.org/10.1002/dmrr.3267 . Epub 2020 Jan 9. (PMID: 31916377)
Ponikowski P, Voors AA, Anker SD et al. Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. Kardiol Pol. 2016;74(10):1037–1147. Polish. doi: https://doi.org/10.5603/KP.2016.0141 . (PMID: 27748494).
Lipsky BA, Senneville É, Abbas ZG et al. International Working Group on the Diabetic Foot (IWGDF) (2020) Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280. doi: https://doi.org/10.1002/dmrr.3280 .(PMID: 32176444).
Schaper NC, Andros G, Apelqvist J et al. (2012) Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. Feb;28 Suppl 1:218–24. doi: https://doi.org/10.1002/dmrr.2255 . (PMID: 22271741).
Gershater MA, Löndahl M, Nyberg P, Larsson J, Thörne J, Eneroth M, Apelqvist J (2009) Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 52(3):398–407. https://doi.org/10.1007/s00125-008-1226-2 (Epub 2008 Nov 27 PMID: 19037626)
doi: 10.1007/s00125-008-1226-2 pubmed: 19037626
Apelqvist J, Elgzyri T, Larsson J, Löndahl M, Nyberg P, Thörne J (2011) Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg 53(6):1582–8.e2. https://doi.org/10.1016/j.jvs.2011.02.006 (Epub 2011 Apr 23 PMID: 21515021)
doi: 10.1016/j.jvs.2011.02.006 pubmed: 21515021
Meloni M, Izzo V, Giurato L, Cervelli V, Gandini R, Uccioli L (2018) Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers. J Clin Transl Endocrinol 2(11):31–35. https://doi.org/10.1016/j.jcte.2018.01.002.PMID:29686969;PMCID:PMC5910511
doi: 10.1016/j.jcte.2018.01.002.PMID:29686969;PMCID:PMC5910511
Norman PE, Davis WA, Bruce DG, Davis TM (2006) Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the fremantle diabetes Study. Diabetes Care 29(3):575–580. https://doi.org/10.2337/diacare.29.03.06.dc05-1567 (PMID: 16505509)
doi: 10.2337/diacare.29.03.06.dc05-1567 pubmed: 16505509
Meloni M, Izzo V, Giurato L et al. (2021) Peripheral arterial disease in patients with renal-diabetic foot ulcers. J Wound Care 30(8):660–664. https://doi.org/10.12968/jowc.2021.30.8.660 (PMID: 34382847)
doi: 10.12968/jowc.2021.30.8.660 pubmed: 34382847
Martelli E, Federici M (2020) Venous distal bypass should be considered as the gold standard to finally attempt limb salvage in patients with severe critical limb ischemia and diabetic foot, or under dialysis. Acta Diabetol 57(8):1019–1020. https://doi.org/10.1007/s00592-020-01524-6 (Epub 2020 Apr 3 PMID: 32246269)
doi: 10.1007/s00592-020-01524-6 pubmed: 32246269
Meloni M, Izzo V, Da Ros V et al. (2020) Characteristics and outcome for persons with diabetic foot ulcer and no-option critical limb ischemia. J Clin Med 9(11):3745. https://doi.org/10.3390/jcm9113745 (PMCID:PMC7700155)
doi: 10.3390/jcm9113745.PMID:33233329;PMCID:PMC7700155 pubmed: 33233329 pmcid: 7700155
Löndahl M, Katzman P, Fredholm O, Nilsson A, Apelqvist J (2008) Is chronic diabetic foot ulcer an indicator of cardiac disease? J Wound Care 17(1):12–16. https://doi.org/10.12968/jowc.2008.17.1.27915 (PMID: 18210951)
doi: 10.12968/jowc.2008.17.1.27915 pubmed: 18210951
Zellweger MJ, Hachamovitch R, Kang X et al. (2004) Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 25(7):543–550. https://doi.org/10.1016/j.ehj.2004.02.013 (PMID: 15120050)
doi: 10.1016/j.ehj.2004.02.013 pubmed: 15120050
Meloni M, Lazaro-Martínez JL, Ahluwalia R, Bouillet B et al. (2021) Effectiveness of fast-track pathway for diabetic foot ulcerations. Acta Diabetol. 2021 Oct;58(10):1351–1358. https://doi.org/10.1007/s00592-021-01721-x . Epub May 3.(PMID: 33942178); (PMCID: PMC8413149)
Vasquez-Rios G, Nadkarni GN (2020) SGLT2 inhibitors: emerging roles in the protection against cardiovascular and kidney disease among diabetic patients. Int J Nephrol Renovasc Dis 28(13):281–296. https://doi.org/10.2147/IJNRD.S268811
doi: 10.2147/IJNRD.S268811
Qiu M, Ding L, Zhou H (2021) Effects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes: a meta-analysis with trial sequential analysis. Medicine (Baltimore) 100(10):e25121. https://doi.org/10.1097/MD.0000000000025121
doi: 10.1097/MD.0000000000025121 pubmed: 33725910
Lyu J, Li Z, Wei H, Liu D, Chi X, Gong DW, Zhao Q (2020) A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China. Acta Diabetol. https://doi.org/10.1007/s00592-020-01484-x
doi: 10.1007/s00592-020-01484-x pubmed: 32008161 pmcid: 7220880

Auteurs

Marco Meloni (M)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. meloni.marco@libero.it.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy. meloni.marco@libero.it.

Alfonso Bellia (A)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Laura Giurato (L)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Davide Lauro (D)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Luigi Uccioli (L)

CTO Andrea Alesini Hospital, Division of Endocrinology and Diabetes Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH